Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 17 de 17
Filtre
1.
Braz. j. med. biol. res ; 52(6): e8009, 2019. graf
Article Dans Anglais | LILACS | ID: biblio-1001539

Résumé

The progression of myocardial injury secondary to hypertension is a complex process related to a series of physiological and molecular factors including oxidative stress. This study aimed to investigate whether moderate-intensity exercise (MIE) could improve cardiac function and oxidative stress in spontaneously hypertensive rats (SHRs). Eight-week-old male SHRs and age-matched male Wistar-Kyoto rats were randomly assigned to exercise training (treadmill running at a speed of 20 m/min for 1 h continuously) or kept sedentary for 16 weeks. Cardiac function was monitored by polygraph; cardiac mitochondrial structure was observed by scanning electron microscope; tissue free radical production was measured using dihydroethidium staining. Expression levels of SIRT3 and SOD2 protein were measured by western blot, and cardiac antioxidants were assessed by assay kits. MIE improved the cardiac function of SHRs by decreasing left ventricular systolic pressure (LVSP), and first derivation of LVP (+LVdP/dtmax and −LVdP/dtmax). In addition, exercise-induced beneficial effects in SHRs were mediated by decreasing damage to myocardial mitochondrial morphology, decreasing production of reactive oxygen species, increasing glutathione level, decreasing oxidized glutathione level, increasing expression of SIRT3/SOD2, and increasing activity of superoxide dismutase. Exercise training in SHRs improved cardiac function by inhibiting hypertension-induced myocardial mitochondrial damage and attenuating oxidative stresses, offering new insights into prevention and treatment of hypertension.


Sujets)
Animaux , Mâle , Rats , Pression sanguine/physiologie , Stress oxydatif/physiologie , Hypertension artérielle/physiopathologie , Mitochondries du myocarde/physiologie , Cardiomyopathies/prévention et contrôle , Conditionnement physique d'animal/physiologie , Rats de lignée SHR , Rats de lignée WKY , Superoxide dismutase/physiologie , Microscopie électronique à balayage , Modèles animaux de maladie humaine , Cardiomyopathies/physiopathologie , Cardiomyopathies/imagerie diagnostique
2.
Arq. bras. cardiol ; 111(3): 400-409, Sept. 2018. tab, graf
Article Dans Anglais | LILACS | ID: biblio-973754

Résumé

Abstract Background: Caloric restriction is known to impair the cardiac function and morphology in hypertrophied hearts of spontaneously hypertensive rats (SHR); however, the influence of fasting/refeeding (RF) is unknown. Objective: To investigate the fasting/refeeding approach on myocardial remodeling and function. In addition, the current study was designed to bring information regarding the mechanisms underlying the participation of Ca2+ handling and b-adrenergic system. Methods: Sixty-day-old male SHR rats were submitted to food ad libitum (C), 50% food restriction (R50) or RF cycles for 90 days. Cardiac remodeling was assessed by ultrastructure analysis and isolated papillary muscle function. The level of significance considered was 5% (a = 0.05). Results: The RF rats presented lower cardiac atrophy than R50 in relation to C rats. The C rats increased weight gain, R50 maintained their initial body weight and RF rats increased and decreased weight during RF. The RF did not cause functional impairment because the isotonic and isometric parameters showed similar behavior to those of C. The isotonic and isometric cardiac parameters were significantly elevated in RF rats compared to R50 rats. In addition, the R50 rats had cardiac damage in relation to C for isotonic and isometric variables. While the R50 rats showed focal changes in many muscle fibers, the RF rats displayed mild alterations, such as loss or disorganization of myofibrils. Conclusion: Fasting/refeeding promotes cardiac beneficial effects and attenuates myocardial injury caused by caloric restriction in SHR rats, contributing to reduce the cardiovascular risk profile and morphological injuries. Furthermore, RF promotes mild improvement in Ca2+ handling and b-adrenergic system.


Resumo Fundamento: A restrição calórica compromete a função e a morfologia cardíacas em corações hipertrofiados de ratos espontaneamente hipertensos (SHR). No entanto, a influência de ciclo de jejum/Realimentação é desconhecida. Objetivo: Investigar o efeito de ciclos de jejum/realimentação sobre a remodelação e função miocárdica. Além disso, o presente estudo foi desenhado para avaliar os mecanismos subjacentes à participação do trânsito de cálcio (Ca+2) e sistema beta-adrenérgico. Métodos: Neste estudo, SHR machos de 60 dias de idade foram submetidos a alimento ad libitum (grupo C), 50% de restrição alimentar (grupo R50) ou ciclos de RF (grupo RF) por 90 dias. A remodelação cardíaca foi avaliada por meio da análise ultraestrutural e função do músculo papilar isolado. Adotou-se o nível de significância de 5% (a = 0,05). Resultados: Os ratos do grupo RF apresentaram menor atrofia cardíaca do que os do grupo R50 em relação aos do grupo C. Os ratos do grupo C aumentaram peso corporal, os ratos do grupo R50 mantiveram seu peso corporal inicial e os ratos do grupo RF aumentaram e reduziram seu peso durante o ciclo RF. O ciclo RF não causou comprometimento funcional, pois os parâmetros isotônicos e isométricos apresentaram comportamento similar aos dos ratos do grupo C. Os parâmetros cardíacos isotônicos e isométricos mostraram-se significativamente elevados nos ratos do grupo RF em comparação aos dos ratos do grupo R50. Além disso, os ratos do grupo R50 apresentaram dano cardíaco em comparação aos ratos do grupo C quanto às variáveis isotônicas e isométricas. Os ratos do grupo R50 apresentaram alterações focais em muitas fibras musculares, enquanto os ratos do grupo RF apresentaram leves alterações, como perda ou desorganização de miofibrilas. Conclusão: Ciclos de Jejum/Realimentação promovem efeitos benéficos cardíacos e atenuam o dano miocárdico causado por restrição calórica em SHR, contribuindo para reduzir o risco cardiovascular e os danos morfológicos. Além disso, o ciclo de jejum/realimentação promove leve melhora do trânsito do Ca2+ e do sistema beta-adrenérgico.


Sujets)
Animaux , Mâle , Muscles papillaires/métabolisme , Calcium/métabolisme , Jeûne/physiologie , Phénomènes physiologiques nutritionnels chez l'animal/physiologie , Cardiomyopathies/prévention et contrôle , Muscles papillaires/anatomopathologie , Rats de lignée SHR , Facteurs temps , Poids/physiologie , Calcium/analyse , Remodelage ventriculaire/physiologie , Restriction calorique/effets indésirables , Isoprénaline/analyse , Isoprénaline/métabolisme , Contraction myocardique , Cardiomyopathies/anatomopathologie
3.
Nutrire Rev. Soc. Bras. Aliment. Nutr ; 41: 1-7, Dec. 2016. tab
Article Dans Anglais | LILACS | ID: biblio-880596

Résumé

Background: The objective of the study is to evaluate the influence of serum vitamin D concentrations and smoking status in cardiac structure and function. Methods: The participants of this study were healthy women smokers (n = 18, mean age 52.8 years), ex-smokers ( n = 18, mean age 51.7 years), and never smokers ( n = 19, mean age 44.4 years). All participants underwent assessment of body composition, dietary intake, sun exposure frequency, vitamin D serum determination, and echocardiographic assessment. All data underwent statistical analysis. Results: The three groups were classified as overweight. The group of ex-smokers showed significantly higher vitamin D serum concentrations. Smoker group showed a higher posterior wall thickness (PW), left ventricular mass, and left ventricular mass index (LVMI). We identified positive correlations between LVMI and smoking history, PW and vitamin D serum, and body mass index and time of smoking history. Multiple linear regressions showed positive association of smoking history and LVMI and PW, also that serum vitamin D has a positive association with PW. PW was associated with smoking history and serum vitamin D, showing a deleterious effect on the heart of both variables. Conclusions: Smoking habit in adult women was associated with cardiac remodeling, and excess of vitamin Dis associated with the action of smoking on cardiac variables. Thus, higher serum vitamin D values have a deleterious effect on the heart in this model.


Sujets)
Humains , Femelle , Adulte , Adulte d'âge moyen , Cardiomyopathies/prévention et contrôle , Fumer/effets indésirables , Vitamine D/analyse , Vitamine D/usage thérapeutique
4.
Acta cir. bras ; 31(4): 271-277, Apr. 2016. tab, graf
Article Dans Anglais | LILACS | ID: lil-781332

Résumé

PURPOSE: T o investigate the possible protective effect of thymoquinone (TQ) in cisplatin (CP) induced myocardial injury. METHODS: A total of 28 adult male Wistar-Albino rats were randomly and equally divided into four groups as follows: Group 1 (control), Group 2 (CP at 15 mg/kg dose), Group 3 (TQ 40 mg/kg/day for two days prior to CP injection and on third day, CP at 15 mg/kg dose was intraperitoneally administered and TQ treatment continued until fifth day) and Group 4 (TQ at 40mg/kg/day dose for five days). RESULTS: There was a significant increment in CP group in terms of congestion, edema and pycnotic nuclei in myocardial fibers, comparing with other groups. TQ group exhibited significant increase in expression of antiapoptotic protein Bcl-2, comparing with CP group (p<0.05). In only CP administered group, expression of antiapoptotic protein Bcl-2 was lowest comparing with other groups. CONCLUSION: Established data indicate that cisplatin is cardiotoxic and thymoquinone may be useful in treating CP-induced cardiac injury.


Sujets)
Animaux , Mâle , Benzoquinones/pharmacologie , Cisplatine/toxicité , Cardiomyopathies/induit chimiquement , Cardiomyopathies/prévention et contrôle , Antinéoplasiques/toxicité , Antioxydants/pharmacologie , Valeurs de référence , Facteurs temps , Immunohistochimie , Répartition aléatoire , Reproductibilité des résultats , Benzoquinones/usage thérapeutique , Résultat thérapeutique , Rat Wistar , Apoptose/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Protéines proto-oncogènes c-bcl-2/analyse , Protéines proto-oncogènes c-bcl-2/effets des médicaments et des substances chimiques , Myocytes cardiaques/effets des médicaments et des substances chimiques , Cardiotoxicité/étiologie , Cardiotoxicité/anatomopathologie , Cardiotoxicité/prévention et contrôle , Coeur/effets des médicaments et des substances chimiques , Cardiomyopathies/anatomopathologie , Myocarde/anatomopathologie , Antioxydants/usage thérapeutique
5.
Rev. bras. cir. cardiovasc ; 30(2): 139-147, Mar-Apr/2015. tab, graf
Article Dans Anglais | LILACS, SES-SP | ID: lil-748943

Résumé

Abstract Introduction: Although rare, the atrioesophageal fistula is one of the most feared complications in radiofrequency catheter ablation of atrial fibrillation due to the high risk of mortality. Objective: This is a prospective controlled study, performed during regular radiofrequency catheter ablation of atrial fibrillation, to test whether esophageal displacement by handling the transesophageal echocardiography transducer could be used for esophageal protection. Methods: Seven hundred and four patients (158 F/546M [22.4%/77.6%]; 52.8±14 [17-84] years old), with mean EF of 0.66±0.8 and drug-refractory atrial fibrillation were submitted to hybrid radiofrequency catheter ablation (conventional pulmonary vein isolation plus AF-Nests and background tachycardia ablation) with displacement of the esophagus as far as possible from the radiofrequency target by transesophageal echocardiography transducer handling. The esophageal luminal temperature was monitored without and with displacement in 25 patients. Results: The mean esophageal displacement was 4 to 9.1cm (5.9±0.8 cm). In 680 of the 704 patients (96.6%), it was enough to allow complete and safe radiofrequency delivery (30W/40ºC/irrigated catheter or 50W/60ºC/8 mm catheter) without esophagus overlapping. The mean esophageal luminal temperature changes with versus without esophageal displacement were 0.11±0.13ºC versus 1.1±0.4ºC respectively, P<0.01. The radiofrequency had to be halted in 68% of the patients without esophageal displacement because of esophageal luminal temperature increase. There was no incidence of atrioesophageal fistula suspected or confirmed. Only two superficial bleeding caused by transesophageal echocardiography transducer insertion were observed. Conclusion: Mechanical esophageal displacement by transesophageal echocardiography transducer during radiofrequency catheter ablation was able to prevent a rise in esophageal luminal temperature, helping to avoid ...


Resumo Introdução: Apesar de rara, a fístula átrio-esofágica é uma das complicações mais temidas na ablação por radiofrequência da fibrilação atrial pelo alto risco de mortalidade. Objetivo: Este é um estudo prospectivo controlado, realizado durante a ablação por radiofrequência da fibrilação atrial regular, para testar se o deslocamento do esôfago ao manipular o transdutor de ecocardiografia transesofágica poderia ser usado para a proteção de esôfago. Métodos: Setecentos e quatro pacientes (158 mulheres e 546 homens [22,4%/77,6%]; 52,8±14 [17-84] anos), com EF média igual a 0,66±0,8 e com fibrilação atrial refratária ao tratamento medicamentoso, foram submetidos à terapia híbrida com ablação por radiofrequência (isolamento convencional das veias pulmonares e ninhos de fibrilação atrial e ablação de taquicardia de background) com deslocamento do esôfago o mais longe possível do alvo da radiofrequência por manuseio do transdutor de ecocardiografia transesofágica. A temperatura luminal esofágica foi monitorada com e sem deslocamento em 25 pacientes. Resultados: O deslocamento esofágico significativo foi de 4 a 9,1 centímetros (5,9±0,8 cm). Em 680 dos 704 pacientes (96,6%), isso foi o suficiente para permitir a entrega completa e segura de radiofrequência (30W/40ºC/cateter irrigado ou 50W/60ºC/cateter de 8 milímetros) sem sobreposição do esôfago. As alterações médias de temperatura luminal esofágica com e sem deslocamento de esôfago foram de 0,11±0,13ºC versus 1,1±0,4ºC, respectivamente, P<0,01. A radiofrequência teve que ser interrompida em 68% dos pacientes sem deslocamento de esôfago devido ao aumento da temperatura luminal esofágica. Não houve nenhum caso, suspeito ou confirmado, de fístula átrio-esofágica. Foram observados apenas dois sangramentos superficiais causados por inserção do transdutor de ecocardiografia transesofágica. Conclusão: O deslocamento mecânico do esôfago pelo transdutor de ecocardiografia transesofágico durante ...


Sujets)
Humains , Mâle , Femelle , Adolescent , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Jeune adulte , Fibrillation auriculaire/chirurgie , Cardiomyopathies/prévention et contrôle , Ablation par cathéter/effets indésirables , Ablation par cathéter/méthodes , Fistule oesophagienne/prévention et contrôle , Fistule/prévention et contrôle , Fibrillation auriculaire , Cardiomyopathies/étiologie , Ablation par cathéter/instrumentation , Échocardiographie transoesophagienne/instrumentation , Fistule oesophagienne/étiologie , Oesophage/anatomie et histologie , Oesophage/traumatismes , Oesophage , Fistule/étiologie , Atrium du coeur/chirurgie , Atrium du coeur , Études prospectives , Reproductibilité des résultats , Facteurs de risque , Température , Résultat thérapeutique
6.
KMJ-Kuwait Medical Journal. 2013; 45 (4): 307-312
Dans Anglais | IMEMR | ID: emr-139623

Résumé

Statin therapy may be beneficial not only to reduce the risk of vascular events but also to reduce the risk of ventricular arrhythmias and sudden cardiac death. We evaluated the effects of statins on electrophysiologic parameters in patients with ischemic cardiomyopathy and established ventricular tachyarrhythmia. Prospective study. Eleven patients [all male, mean age 57.9 +/- 6.64 years], with ischemic cardiomyopathy and ventricular tachyarrhythmia on admission were included in the study. Two academic tertiary care centers. A baseline electrophysiologic study was performed before implantable-cardioverter defibrillator [ICD] implantation. Forty milligram of atorvastatin was started and electrophysiologic study was repeated one month later and results were compared. Basic intervals, corrected sinus node recovery time [cSNRT], sino-atrial conduction time [SACT], atrio-ventricular node refractory period [AVNRP], atrio-ventricular Wenckebach period [AVWP], ventricular refractory period [VRP], ventriculo-atrial dissociation measurement, corrected QT [QTc] interval and QT dispersion were measured. Also, ventricular arrhythmia inducibility was evaluated with various techniques. Although, QTc interval and QT dispersion decreased significantly with statin treatment [p < 0.05], there were no statistically significant differences in the measurements of basic intervals, cSNRT, SACT, AVNRP, AVWP, VRP and ventriculo-atrial dissociation compared to pretreatment measurements [p > 0.05]. Additionally, while induction of ventricular tachyarrhythmia occurred in 72.7% of patients before statin therapy, this rate decreased to 36.4% with treatment [p - 0.13]. Statin treatment led to significant decreases in QTc interval and QT dispersion, but it did not change other electrophysiologic parameters significantly


Sujets)
Humains , Mâle , Cardiomyopathies/prévention et contrôle , Tachycardie ventriculaire/prévention et contrôle , Techniques électrophysiologiques cardiaques , Mort subite cardiaque/prévention et contrôle , Études prospectives
7.
Rev. SOCERJ ; 22(5): 281-288, set.-out. 2009. graf, tab
Article Dans Portugais | LILACS | ID: lil-540217

Résumé

O câncer de mama tem alta prevalência e para o seu tratamento usam-se, com frequência, quimioterápicos, inclusive a doxorrubicina (doxo), que podem ocasionar cardiotoxicidade. Analisar os achados eletrocardiográficos em mulheres com câncer de mama que desenvolveram cardiomiopatia após o uso de doxorrubicina. Estudo caso-controle retrospectivo onde foram analisados os eletrocardiogramas (ECG) e ecocardiograma (ECO) de mulheres com câncer de mama que fizeram uso da doxorrubicina, objetivando diagnosticar a disfunção sistólica e avaliar alterações no ECG. No ECG foi avaliado o QT, o QTC e a frequência cardíaca. Foram analisados 254 prontuários e selecionados 38, sendo 22 de pacientes que não apresentavam disfunção miocárdica (Grupo A) e 16 pacientes que apresentaram disfunção miocárdica (Grupo B). Resultados: No grupo B houve uma redução importante da fração de ejeção (FE) do ventrículo esquerdo (VE) (FE) antes=67 por cento; depois=39 por cento; p=0,0001). No ECG, a análise da dispersão do QT...


Sujets)
Humains , Femelle , Adulte , Adulte d'âge moyen , Cardiomyopathies/prévention et contrôle , Doxorubicine , Doxorubicine/pharmacologie , Tumeurs du sein/complications , Tumeurs du sein/traitement médicamenteux , Échocardiographie/méthodes , Électrocardiographie/méthodes
8.
Ann Card Anaesth ; 2009 Jul; 12(2): 133-135
Article Dans Anglais | IMSEAR | ID: sea-135167

Résumé

The repair of abdominal aortic aneurysm (AAA) in the presence of significant coronary artery disease (CAD) carries a high-risk of adverse peri-operative cardiac event. The options to reduce cardiac risk include perioperative β-blockade, preoperative optimization by myocardial revascularization and simultaneous (combined) coronary artery bypass grafting and aneurysm repair. We describe intra-operative controlled phlebotomy to optimize myocardial stress during repair of infrarenal AAA in a patient with significant stable CAD.


Sujets)
Antagonistes bêta-adrénergiques/usage thérapeutique , Sujet âgé , Anesthésie générale , Anévrysme de l'aorte abdominale/complications , Anévrysme de l'aorte abdominale/chirurgie , Aténolol/usage thérapeutique , Procédures de chirurgie cardiaque , Cardiomyopathies/prévention et contrôle , Maladie des artères coronaires/complications , Humains , Mâle , Revascularisation myocardique , Phlébotomie
9.
Hamdard Medicus. 2008; 51 (3): 38-41
Dans Anglais | IMEMR | ID: emr-102203

Résumé

In the present study, ethanolic Zingiber officinale extract was prepared and studied for antioxidant and cardioprotective effect against isoproterenol-induced myocardial necrosis in rats. The present study indicates that the ethanolic Zingiber officinale extract post treatment possess significant antioxidant and cardioprotective activity


Sujets)
Mâle , Femelle , Animaux de laboratoire , Plantes médicinales , Extraits de plantes , Cardiotoniques/pharmacologie , Rat Wistar , Isoprénaline , Modèles animaux de maladie humaine , Cardiomyopathies/prévention et contrôle , Piégeurs de radicaux libres
10.
Arq. bras. med. vet. zootec ; 57(supl.2): 141-148, set. 2005. tab
Article Dans Portugais | LILACS | ID: lil-432005

Résumé

Foram avaliados os efeitos clínicos do benazepril, um inibidor da enzima de conversão da angiotensina de ação prolongada, em cães com insuficiência cardíaca congestiva (ICC) secundária à endocardiose de mitral ou cardiomiopatia dilatada. O medicamento foi administrado na dose de 0,25 a 0,5mg/kg/dia. Diuréticos, digitálicos e fármacos antiarrítmicos froam usados de acordo com a necessidade de cada paciente. Exames físico, radiográfico e eletrocardiográfico foram realizados nos dias 0, 7, 28 e 56. A gasometria arterial e a bioquímica sérica foram avaliadas nos dias 0 e 56. Os sinais de dispnéia e o estado geral dos pacientes melhoraram em todos os cães após o início do tratamento. Houve diminuição na frequência da tosse e não houve alterações no eletrocardiograma, exceto pela diminuição na amplitude e na duração da onda P. Nenhum efeito colateral foi observado. Conclui-se que o benazepril é um inibidor da enzima de conversão da angiotensina, eficaz e bem tolerado no tratamento da ICC no cão.


Sujets)
Animaux , Mâle , Femelle , Cardiomyopathies/prévention et contrôle , Cardiomyopathies/thérapie , Chiens , Inhibiteurs de l'enzyme de conversion de l'angiotensine/administration et posologie , Défaillance cardiaque/prévention et contrôle , Défaillance cardiaque/thérapie
11.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 14(2): 239-249, mar.-abr. 2004.
Article Dans Portugais | LILACS | ID: lil-406402

Résumé

Nos últimos anos, a morte súbita tem sido extensivamente estudada porque é responsável por centenas de milhares de eventos fatais, principalmente nos países desenvolvidos e/ou em desenvolvimento, acometendo pessoas cada vez mais jovens, não raramente com destaque na mídia. Mister se faz avançar cada vez mais na direção de identificar indivíduos sob risco, derivando daí sua possível prevenção. Neste artigo são revistas as principais causas de morte súbita bem como os métodos possíveis empregados para a identificação de pessoas suscetíveis. Não será delineada a totalidade de causas conhecidas de morte súbita porque nem todas são passíveis de estratificação de risco (por exemplo, alterações hidroeletrolíticas). Entre as causas mais importantes serão discutidos os aspectos relativos à doença isquêmica cardíaca, às cardiomiopatias hipertrófica e dilatada, às síndromes eletrogenéticas, às que acometem indivíduos com coração estruturalmente normal, aos distúrbios do sistema excitocondutor e aos tumores cardíacos


Sujets)
Humains , Adulte , Troubles du rythme cardiaque , Ischémie myocardique/physiopathologie , Cardiomyopathies/complications , Cardiomyopathies/diagnostic , Cardiomyopathies/physiopathologie , Cardiomyopathies/mortalité , Cardiomyopathies/prévention et contrôle , Mort subite/anatomopathologie , Mort subite/prévention et contrôle , Infarctus du myocarde/physiopathologie , Infarctus du myocarde/mortalité , Infarctus du myocarde/prévention et contrôle
14.
La Paz; Bruño; 1997. 107 p.
Monographie Dans Espagnol | LILACS, LIBOCS, LIBOE, LIBOSP | ID: lil-233368

Résumé

El libro consta de dos secciones: la primera como enfrentar la fiebre reumática, permite al médico en general y al estudiante de medicina familiarizarse con una patología que en las regiones altas y frias del país es la responsable de la mayoría de las cardiopatías de la segunda infancia y del adulto joven, y que puede ser prevenido eficazmente a bajo costo. La sección sobre cardiopatía congénitas, sirve por su seleccionada metodología, de introducción, orientación y consulta permanente para el médico que busca una visión simple, práctica y actualizada de cada problema


Sujets)
Humains , Cardiomyopathies/prévention et contrôle , Cardiopathies congénitales , Rhumatisme articulaire aigu , Bolivie
16.
P. R. health sci. j ; 5(1): 19-25, Apr. 1986. tab
Article Dans Anglais | LILACS | ID: lil-96438

Résumé

Los efectos de TP-V, una solución hiperosmolar con dextrosa, sucrosa, y ATP-MgCl2 fueron estudiados cuando usada sola o en combinación con substancias que eliminan los radicales libres de oxigenio, por 24 horas de perfusión hipotermica pulsátil de corazón pulmón y después revalorados en un sistema aislado de corazón pulmón a 37-C. Tres grupos de corazón pulmón de perros se analizaron: 1) TP-V (n=6), 2) TP-V con alopurinol (500mg/L) (m=6), 3) TP-V con alopurinol (500mg/L) y catalase (5000U/L) (n=5). Después de 24 horas de preservación, la preparación corazón pulmón fue perfundida con albúmina-manitol por 3 horas a 37-C con objeto de estimar su capacidad funcional y hemodinámica. Grupos 2 y 3 mostraron mejores valores de LDH y CPK a 0 t 3 horas de perfusión. Los valores de pH, pCO2, también como la presión ventricular izquierda, coronaria y aórtica, no cambinaron en forma significante. Histologicamente, el grupo 3 mostró mejor preservación del corazón y pulmones. En resúmen, podemos indicar que la solución TP-V, con las substancias que eliminan radicales libres de oxigeno, ofrecen una buena protección para la preparación corazón pulmón almacenada por 24 horas bajo hipotermia


Sujets)
Chiens , Animaux , Cardiomyopathies/prévention et contrôle , Ischémie/prévention et contrôle , Maladies pulmonaires/prévention et contrôle , Conservation d'organe , Allopurinol/usage thérapeutique , Catalase/usage thérapeutique , Vaisseaux coronaires , Radicaux libres , Hypothermie provoquée , Oxygène/usage thérapeutique , Perfusion , Poumon/vascularisation , Superoxydes/usage thérapeutique
SÉLECTION CITATIONS
Détails de la recherche